# Daiichi Sankyo Company, Limited (DSNKY)

> Source: Nexqual · https://nexqual.com/DSNKY · data as of 2026-10-23 17:05 UTC · cite as "Nexqual, Daiichi Sankyo Company, Limited (DSNKY), nexqual.com/DSNKY" · informational, not investment advice.

**Price:** USD 17.85 (-1.33% today) · US market open, as of October 23, 2026 at 17:05 UTC; quotes may be delayed. Prev close 18.09 · day 17.83–17.92 · 52w 14.98–26.8 · market cap $32.5B · PNK

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 23.35 (range 22–24.7).
- Total return with dividends: 1Y -33.5% vs S&P 500 +14.4%; 5Y -28.6% vs S&P 500 +77.0%.
- Next earnings: 2026-10-30, EPS estimate USD —, revenue estimate $566B.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 23.35 (low 22, high 24.7).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -33.5% | -28.6% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -33.5% | -6.5% |
| Volatility (annualized) | 40.8% | 36.0% |
| Max drawdown | -43.7% (Oct 2025→Jun 2026) | -62.9% (Aug 2024→Jun 2026) |

## Peers (Drug Manufacturers - General)
BIIB (Biogen Inc.) USD 250.37 -1.37% · SNY (Sanofi) USD 41.5 -1.11% · GSK (GSK plc) USD 50.63 -1.13% · BMY (Bristol-Myers Squibb Company) USD 61.55 -2.31% · PFE (Pfizer, Inc.) USD 29.98 -1.46% · NVO (Novo Nordisk A/S) USD 39.02 -1.04%

## More
Full page: https://nexqual.com/DSNKY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $566.08B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $595.53B | — |
| Current fiscal year (ends 2027-03-31) | $0.91 | $0.93 | -1.6% | $2.36T | 2 |
| Next fiscal year (ends 2028-03-31) | $1.14 | $1.08 | +5.9% | $2.40T | 1 |